-
Entire Site
Products
Part Numbers
Applications
Technical Documents
Entire Site
Products
Part Numbers
Applications
Technical Documents
Torrance, CA (January 5, 2015) – Phenomenex Inc., a global leader in the research and manufacture of advanced technologies for the separation sciences, announces Kinetex F5 – a robust pentafluorophenyl propyl (PFP) core-shell phase that overcomes reproducibility and performance limitations of existing PFP and F5 products on the market. After extensive internal and external testing found that existing PFP and F5 fully porous and core-shell products produced sporadic basic compound adsorption and analyte retention time shifting, Phenomenex, in partnership with customers, redefined the industry standard and developed this new core-shell pentafluorophenyl.
The new Kinetex F5 phase delivers improved reproducibility compared to other PFP or F5 columns on the market and can significantly reduce method development time with its dynamic and responsive chemical functionality. It is an ideal solution for HPLC/UHPLC development work with its combination of polar and non-polar interactions including hydrogen bonding, electrostatic, hydrophobic, aromatic and steric/planar mechanisms. Additional versatility of this phase gives scientists the ability to use reversed phase, 2D-LC, HILIC, SFC or even 100 percent aqueous separation modes. With its fluorinated groups and carbon ring structure, the Kinetex F5 is an excellent choice for both polar and non-polar compound separations as well as challenging methods that include halogenated, conjugated or isomeric compounds.
Kinetex F5 is available in 2.6 and 1.7 µm particle sizes and delivers all the advantages of Phenomenex’ Core-Shell Technology including better resolution, higher efficiency, easy method transferability and cost savings from reduced solvent consumption. The Kinetex 2.6 µm F5 provides performance comparable to sub-2 µm particles on both standard HPLC and UHPLC systems. The 1.7 µm column delivers 20 percent greater efficiencies than fully porous sub-2 µm products.
“Our company truly values the customers’ voice and working beyond the status quo,” explains Simon Lomas, brand manager for Phenomenex. “These new Kinetex F5 columns are the result of years of research, development and customer input. With better, more accurate and higher performance products like the Kinetex core-shell F5, scientists can continue to push the current limits of separation science.
Contact:
Phenomenex Press Room.
Phone: (310) 212-0555 Ext. 2243
E-mail: pressroom@phenomenex.com
Publish Date | Publication | Article Title |
---|---|---|
12/13/2019 | Cannabis testing: The need for robust methods and true transparency | |
05/08/2019 | Rapid Extraction and Analysis of PPCPs From Sediments |
Publish Date | Publication | Article Title |
---|---|---|
11/14/2018 | Chromatographic Analysis for PAT | |
11/12/2018 | High-Flow Weak Cation Exchange for Charge Variant Analysis | |
06/01/2018 | Bio-Inert versus Bio-Compatible: The Benefits of Different Column Materials in Liquid Chromatography... | |
02/23/2018 | Meeting the Demands of the Food Safety Laboratory Using Versatile Columns |
Publish Date | Publication | Article Title |
---|---|---|
07/18/2017 | SelectScience Interview: Improving Food Safety at the United States Department of Agriculture | |
06/20/2017 | Addressing the Challenges of Drug-to-Antibody Measurement | |
02/24/2017 | Dietary Supplements Method Modernization- A Review of Current Efforts to Modetnize Compendial Method... | |
02/14/2017 | How to Optimize Your Reversed Phase Chromatography |
Publish Date | Publication | Article Title |
---|---|---|
12/14/2016 | Customized Separation Solutions from PhenoLogix Experts | |
11/02/2016 | The Secrets Behind the Success of Phenomenex- Tips to the Top | |
10/06/2016 | The Phenomenex Story Part II: Leading the Field in Urine Analysis | |
09/27/2016 | Urinary Drug Testing: Small Changes for Big Improvements in Sensitivity | |
09/22/2016 | The Phenomenex Story Part I: The Architect Who Build a Chemistry Empire | |
07/6/2016 | Urine Analytics: The Good, The Bad, and The Ugly | |
07/20/2016 | Approaches to prescription opioid abuse testing |
Publish Date | Publication | Article Title |
---|---|---|
12/10/2015 | Allowable Adjustments to Pharmacopoeia Methods for Isocratic and Gradient Separations | |
10/1/2015 | New Approaches to Screening for Drug Abuse | |
04/09/2015 | Torrance Tribune - Crushing Malaria | |
03/03/2015 | Identifying the Increased Scope of Core-Shell Technology for HPLC and UHPLC Chromatographers |
Publish Date | Publication | Article Title |
---|---|---|
12/02/2014 | Eliminating Volumetric Haematocrit Bias Associated with DBS Sub-Punch Workflows Using a Novel Micros... |